ACT EU: Launch of Two New Pilot Projects for Scientific Advice and Clinical Trials in Europe

The Accelerating Clinical Trials in the EU (ACT EU) initiative has launched two pilot projects aimed at improving the quality…

READ

Certificate of Pharmaceutical Product as strategic plan for Extra – EU market: how to request it to AIFA.

The Certificate of Pharmaceutical Product (CPP) is a document issued by a country’s regulatory authority at the request of a…

READ

Clinical Trials – CCNCE Report on Ethical Committees

The National Coordination Center for Ethical Committees (CCNCE) report highlights critical issues and recommendations for Italy’s 40 Territorial Ethical Committees…

READ

The Impact of AI on Pharmaceutical Regulatory Processes

Over the past few years, the use of Artificial Intelligence (AI) in pharmaceutical industry is rapidly expanding. AI is a…

READ

Italian Medical Devices Database: Important Updates for Legacy Devices

Legacy devices are those that were approved under the previous MDD but are still in use or available on the…

READ

Transparency in Healthcare domain: Transfers of value

The transparency of transfers of value declared by pharmaceutical companies is crucial for maintaining trust and integrity within the healthcare…

READ

EMA’S NEW GUIDELINES ON ENVIRONMENTAL RISK ASSESSMENT FOR HUMAN MEDICINAL PRODUCTS

The European Medicines Agency (EMA) has recently published a significant update to its guideline on Environmental Risk Assessment (ERA) for…

READ

The regulation of the Scientific-Economic Commission of Pharmaceuticals of AIFA

The regulation detailing the organization and functioning of the Scientific-Economic Commission of Pharmaceuticals (CSE) of the Italian Medicines Agency (AIFA)…

READ

Transitioning to CTIS: Key Steps and Documentation Required

The transition of clinical trial applications from the Directive 2001/20/EC (CTD) to the Regulation EU No 536/2014 (CTR), facilitated by…

READ

Clarifying “Day Zero” in Medical Literature Reporting: focus on paper journals.

According to GVP (Good Pharmacovigilance Practices) Module VI, MAHs are required to conduct actively global literature searches at least once…

READ